μ₯μ¬μ ν
μ₯μ¬μ νμ λ¨κΈ° λ΄μ§ μ€κΈ° μμ©μ νλ **λ²€μ‘°λμμ νκ³** μ½λ¬Όλ‘, μμνμμλ μ£Όλ‘ κ°μ κ³ μμ΄μ **μμμ΄μ§μ ** λ° **νλΆμμ **λ‘ μ¬μ©λ©λλ€. **μμμ νΉμ§ λ° μ½λ¦¬νμ μ₯μ :** * **λμ¬ νλ‘ν:** λμμ νκ³Ό λ¬λ¦¬ μ₯μ¬μ νμ 1μ κ° λμ¬(μ°ν)λ₯Ό κ±°μΉμ§ μμΌλ©° νμ± λμ¬ μ°λ¬Όμ΄ μμ΅λλ€. μ€μ§ 2μ κΈλ£¨μΏ λ‘ μ° ν¬ν©μ ν΅ν΄μλ§ λμ¬λ©λλ€. * **λ Έλ Ή λ° κ°μ§ν νμμ μμ μ±:** λμ¬ κ²½λ‘κ° λ¨μνκΈ° λλ¬Έμ λ Έλ Ή νμλ κ²½λμμ μ€λ±λμ κ° κΈ°λ₯ μ₯μ κ° μλ νμμκ² λμμ νλ³΄λ€ μμ ν λμμΌλ‘ κ°μ£Όλλ κ²½μ°κ° λ§μ΅λλ€. * **κ³ μμ΄ μ£Όμμ¬ν:** μ 리ν λμ¬ νλ‘νμλ λΆκ΅¬νκ³ , νΉμ΄μ²΄μ§μ± μ κ²©μ± κ°λΆμ μ μΌμΌν¨λ€λ λλ¬Έ μΌνμ λ³΄κ³ κ° μμ΄ μ§λ°©κ°μ΄λ μ€μ¦ κ° κΈ°λ₯ μ₯μ κ° μλ κ³ μμ΄μμμ μ¬μ©μ μ¬μ ν λ Όλμ μ¬μ§κ° μμ΅λλ€. * **νλ μΉλ£ μ©λ:** 곡ν¬, 곡ν¬μ¦ λ° μλ³ νμ νλμ λν 보쑰 경ꡬ νλΆμμ λ‘ μ¬μ©λμ§λ§, κ°νΉ μμ€μ ν₯λΆμ΄ λ°μν μ μμ΅λλ€.
μμ© κΈ°μ : Oxazepam acts as a positive allosteric modulator at the **GABA-A receptor** complex in the central nervous system. * **Binding:** It binds to specific benzodiazepine recognition sites on the **GABA-A** ligand-gated chloride channel. * **Mechanism:** It enhances the inhibitory effect of **gamma-aminobutyric acid (GABA)** by increasing the *frequency* of chloride channel openings. * **Pathway:** Influx of chloride ions β **neuronal hyperpolarization** β decreased neuronal excitability. * **Clinical Effect:** This depression of subcortical CNS levels (primarily limbic, thalamic, and hypothalamic) produces the characteristic anxiolytic, sedative, skeletal muscle relaxant, and anticonvulsant effects.
λλ¬Ό μ’ λ³ μ©λ
- Appetite stimulant Β· 2 mg per cat (total dose) Β· PO Β· every 12 hours
- Appetite stimulant (hepatic lipidosis) Β· 0.1-0.3 mg/kg Β· PO Β· q12-24h Β· If cat has a small interest in eating
- Appetite stimulant Β· 0.25-0.5 mg/kg Β· PO Β· one to two times daily
- Fears and phobias Β· 1-2.5 mg per cat (total dose) Β· PO Β· every 12 hours
- Fears and phobias Β· 0.2-0.5 mg/kg Β· PO Β· q12-24h
- Feline urine marking Β· 0.2-0.5 mg/kg Β· PO Β· once to twice a day
- Spraying or overgrooming Β· 0.2-0.5 mg/kg Β· PO Β· q12-24h
- Fears and phobias Β· 0.2-1 mg/kg Β· PO Β· q12h or q6h Β· The lowest dose and longest frequency between doses that alleviate the fear should be used.
- Fears and phobias Β· 0.2-0.5 mg/kg Β· PO Β· q12-24h
- Fears and phobias Β· 0.2-1 mg/kg Β· PO Β· q12-24h
- Fears and phobias Β· 0.2-1 mg/kg Β· PO Β· one to two times a day
- Fears and phobias Β· 0.04-0.5 mg/kg Β· PO Β· q6h Β· The lowest dose and longest frequency between doses that alleviate the fear should be used.
ν¬μ¬ κ²½λ‘
κΈκΈ°
- Known benzodiazepine hypersensitivity
- Acute narrow angle glaucoma
μ΄μλ°μ
- Sedation (most common)
- Ataxia
- Paradoxical excitability, vocalization, or aggression
- Rebound anxiety or behavior worsening (if withdrawn abruptly)
- Rare precipitation of tonic-clonic seizures
- Rare idiosyncratic fulminant hepatic failure (cats)
μ½λ¬Ό μνΈμμ©
- CNS Depressant Drugs (barbiturates, narcotics, anesthetics) Β· Additive CNS depression effects may occur.
- Phenytoin Β· May decrease oxazepam concentrations.
- Probenecid Β· May impair glucuronide conjugation (in dogs) and prolong effects.
- Rifampin Β· May induce hepatic microsomal enzymes and decrease the pharmacologic effects of benzodiazepines.
- St. John's Wort Β· May decrease oxazepam effectiveness.
- Theophyllines Β· May decrease oxazepam effectiveness.
λͺ¨λν°λ§
- Clinical efficacy (improved appetite, reduced anxiety/fear)
- Adverse effects (degree of sedation, ataxia, paradoxical excitement)
κ³Όμ©λ
**Signs of Toxicity:** When used alone, overdoses are generally limited to significant CNS depression (confusion, coma, decreased reflexes, profound sedation). **Treatment:** * **Decontamination:** Standard protocols for removing and/or binding the drug in the gut (e.g., emesis induction if asymptomatic and recent, activated charcoal) if taken orally. * **Supportive Care:** Systemic supportive measures (IV fluids, warming, respiratory support if needed). * **Antidote:** **Flumazenil** (a specific benzodiazepine antagonist) could potentially be used in life-threatening overdoses. * **Contraindications:** The use of analeptic agents (CNS stimulants such as caffeine, amphetamines) is generally not recommended.
VetSheet μ½λ¬Ό λ νΌλ°μ€λ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μμ¬κ²°μ 보쑰 λꡬμ΄λ©°, μ λ¬Έμ νλ¨μ΄λ μ μ‘°μ¬μ μ΅μ λΌλ²¨μ λμ νμ§ μμ΅λλ€.